To access this element change to forms mode OFF
Grant Award View - GA217930
A randomised, double-blind, controlled trial of MDMA-assisted exposure...
GA ID:
GA217930
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,951,246.45
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
A randomised, double-blind, controlled trial of MDMA-assisted exposure therapy for comorbid alcohol use disorder and post-traumatic stress disorder
Purpose:
There is a high rate of comorbidity between alcohol use disorders and post traumatic stress disorder which is associated with greater clinical impairment, poorer prognosis and greater treatment attrition. This trial will be an internationally unique study which will examine the efficacy of MDMA-assisted therapy to treat concurrent alcohol use disorder and post traumatic stress disorder. This study will generate high level efficacy and cost-efficacy data for these life-threatening problems.
GO ID:
GO Title:
MRFF - Clinical Trials Activity Initiative - 2021 Innovative Therapies for Mental Illness - Grant Opportunity
Internal Reference ID:
2021/MRF2014615
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA